Cargando…
Living Organ Donor Health Care Priorities During the COVID-19 Pandemic
Autores principales: | Zaidi, Hasan, Klassen, Ann C., Fleetwood, Janet, Lentine, Krista L., Reese, Peter P., Mittelman, Michael, Bertha, Rebecca, Harhay, Meera N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857996/ https://www.ncbi.nlm.nih.gov/pubmed/33558854 http://dx.doi.org/10.1016/j.ekir.2021.01.031 |
Ejemplares similares
-
Use of Organs from SARS-CoV-2 Infected Donors: Is It Safe? A Contemporary Review
por: Kute, Vivek B., et al.
Publicado: (2021) -
Policy Strategies to Reduce Financial Risks for Living Donors
por: Husain, Syed Ali, et al.
Publicado: (2023) -
Validation of Living Donor Nephrectomy Codes
por: Lam, Ngan N., et al.
Publicado: (2018) -
Solid Organ Transplantation in SARS-CoV-2 Recovered Transplant Candidates: a Comprehensive Review of Recent Literature
por: Kute, Vivek, et al.
Publicado: (2022) -
End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?
por: Lam, Ngan N., et al.
Publicado: (2014)